Artal Group’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-250,000
| Closed | -$2.31M | – | 130 |
|
2022
Q3 | $2.31M | Buy |
+250,000
| New | +$2.31M | 0.1% | 83 |
|
2020
Q4 | – | Sell |
-95,000
| Closed | -$2.42M | – | 140 |
|
2020
Q3 | $2.42M | Sell |
95,000
-5,000
| -5% | -$127K | 0.06% | 106 |
|
2020
Q2 | $2.89M | Sell |
100,000
-25,000
| -20% | -$722K | 0.08% | 102 |
|
2020
Q1 | $6.02M | Hold |
125,000
| – | – | 0.25% | 57 |
|
2019
Q4 | $7.11M | Hold |
125,000
| – | – | 0.27% | 51 |
|
2019
Q3 | $7.75M | Buy |
+125,000
| New | +$7.75M | 0.31% | 48 |
|
2018
Q2 | – | Sell |
-37,500
| Closed | -$1.88M | – | 100 |
|
2018
Q1 | $1.88M | Buy |
37,500
+6,087
| +19% | +$304K | 0.02% | 69 |
|
2017
Q4 | $1.52M | Hold |
31,413
| – | – | 0.02% | 69 |
|
2017
Q3 | $1.91M | Hold |
31,413
| – | – | 0.03% | 64 |
|
2017
Q2 | $2.22M | Hold |
31,413
| – | – | 0.04% | 68 |
|
2017
Q1 | $2.04M | Hold |
31,413
| – | – | 0.05% | 60 |
|
2016
Q4 | $2.95M | Buy |
31,413
+6,413
| +26% | +$603K | 0.07% | 43 |
|
2016
Q3 | $2.82M | Buy |
+25,000
| New | +$2.82M | 0.06% | 50 |
|